Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels | MicrobiomeTrials
Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-06-02Est. Completion: 2028-06
Enrollment target: 54 participants
Locations
Smilow Cancer Center, New Haven, Connecticut, United States